TrustRadius

Advarra OnCore vs. Quanta View

Overview
ProductRatingMost Used ByProduct SummaryStarting Price
Advarra OnCore
Score 4.0 out of 10
N/A
OnCore, from Advarra in Columbia (formerly known as Forte Research Systems) provides automated clinical research support featuring, billing and financial management, specimen management, reporting, effort tracking, and integration into other clinical systems.N/A
Quanta View
Score 0.0 out of 10
N/A
Quanta View, "The Clinical eBox" is a multi-function Web application (e-CRF and CTMS). A modular, multi-lingual solution, it adapts to different study designs and boasts various functionalities. It is described by the vendor as simple to use, and they state the application meets both the expectations of a non-interventional study and those of a comparative interventional study.N/A
Pricing
Advarra OnCoreQuanta View
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
Advarra OnCoreQuanta View
Free Trial
NoNo
Free/Freemium Version
NoNo
Premium Consulting/Integration Services
NoNo
Entry-level Setup FeeNo setup feeOptional
Additional Details——
More Pricing Information
Community Pulse
Advarra OnCoreQuanta View
User Ratings
Advarra OnCoreQuanta View
Likelihood to Recommend
9.0
(1 ratings)
-
(0 ratings)
User Testimonials
Advarra OnCoreQuanta View
Likelihood to Recommend
Advarra (formerly Forte Research System)
Advarra is well suited for monitoring the progress of the clinical trials for a research organization. It's biggest advantage is the fact that the participants details and accrual monitoring shows the progress of the clinical trial. OnCore provides the capability of creating and using study calendars and especially monitoring and tracking participants visits. OnCore may be less appropriate to use in regards to grants and funds tracking.
Verified User
Anonymous
Read full review
QUANTA MEDICAL
No answers on this topic
Alternatives Considered
Advarra (formerly Forte Research System)
I have not used nor evaluated any other products similar to Advarra OnCore. Did not participate in the selection process.
Verified User
Anonymous
Read full review
QUANTA MEDICAL
No answers on this topic
ScreenShots